Product Information
TRINTELLIX 5 MG TABLET is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $17.1968 per EA under NDC 64764072030. Its NADAC has been published 539 times since Jun 8, 2016.
FDA first approved this application on Sep 30, 2013.
Strength
5 mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
64764072030
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VORTIOXETINE HYDROBROMIDEApproval Type
New Drug (NDA)
FDA Application
NDA204447FDA Approved
9/30/2013
On Market Since
10/2/2013
Price Statistics
The NADAC for TRINTELLIX 5 MG TABLET has been published 539 times since Jun 8, 2016, and over the history we have for it it has risen 66.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.1968 per EA |
|---|---|
| All-time high | $17.2395 (May 13, 2026) |
| All-time low | $10.1651 (Aug 17, 2016) |
| 52-week high | $17.2395 |
| 52-week low | $16.4091 |
| Median price | $13.5528 |
| Average price | $13.7246 |
| Largest weekly change | +9.0% (Jan 10, 2018) |
| Weeks tracked | 539 |
| Tracking since | Jun 8, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the vortioxetine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Takeda Pharmaceuticals America, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
vortioxetine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRINTELLIX 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRINTELLIX 5 MG TABLET, manufactured by Takeda Pharmaceuticals America, Inc., is $17.1968 per EA (NDC 64764072030), effective Sep 30, 2026.
How has the price of TRINTELLIX 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRINTELLIX 5 MG TABLET has risen 66.9%. It has been tracked across 539 weekly CMS publications since Jun 8, 2016.
What are the highest and lowest recorded NADAC prices for TRINTELLIX 5 MG TABLET?
Since Jun 8, 2016, the NADAC for TRINTELLIX 5 MG TABLET has ranged from a low of $10.1651 (Aug 17, 2016) to a high of $17.2395 (May 13, 2026), with a median of $13.5528 per EA.
Are there cheaper alternatives to TRINTELLIX 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of TRINTELLIX 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TRINTELLIX 5 MG TABLET?
TRINTELLIX 5 MG TABLET (NDC 64764072030) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.